Global Dendritic Cell Cancer Vaccine Market Growth 2021-2026

  • receipt Report ID : 244437
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 167
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2020 growth of Dendritic Cell Cancer Vaccine will have significant change from previous year. By the most conservative estimates of global Dendritic Cell Cancer Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Dendritic Cell Cancer Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Dendritic Cell Cancer Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

CreaVax

Sipuleucel-T (Provenge)

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Pediatrics

Adults

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Medigene

Activarti

Argos Therapeutics

Batavia Bioservices

Bellicum Pharmaceuticals

Creagene

DanDrit Biotech

DCPrime

Sanpower (Dendreon)

Elios Therapeutics

Immunicum

Kiromic

Merck

Northwest Biotherapeutics

Glaxo Smith Kline

ImmunoCellular

Tella

Vaxil Bio

Medigene

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dendritic Cell Cancer Vaccine Consumption 2016-2026

2.1.2 Dendritic Cell Cancer Vaccine Consumption CAGR by Region

2.2 Dendritic Cell Cancer Vaccine Segment by Type

2.2.1 CreaVax

2.2.2 Sipuleucel-T (Provenge)

2.2.3 Others

2.3 Dendritic Cell Cancer Vaccine Sales by Type

2.3.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Type (2016-2021)

2.4 Dendritic Cell Cancer Vaccine Segment by Application

2.4.1 Pediatrics

2.4.2 Adults

2.5 Dendritic Cell Cancer Vaccine Sales by Application

2.5.1 Global Dendritic Cell Cancer Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Dendritic Cell Cancer Vaccine Sale Price by Application (2016-2021)

3 Global Dendritic Cell Cancer Vaccine by Company

3.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Company

3.1.1 Global Dendritic Cell Cancer Vaccine Sales by Company (2019-2021)

3.1.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company

3.2.1 Global Dendritic Cell Cancer Vaccine Revenue by Company (2019-2021)

3.2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Dendritic Cell Cancer Vaccine Sale Price by Company

3.4 Global Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dendritic Cell Cancer Vaccine Product Location Distribution

3.4.2 Players Dendritic Cell Cancer Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Dendritic Cell Cancer Vaccine by Region

4.1 Global Dendritic Cell Cancer Vaccine by Region

4.1.1 Global Dendritic Cell Cancer Vaccine Sales by Region

4.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Region

4.2 Americas Dendritic Cell Cancer Vaccine Sales Growth

4.3 APAC Dendritic Cell Cancer Vaccine Sales Growth

4.4 Europe Dendritic Cell Cancer Vaccine Sales Growth

4.5 Middle East & Africa Dendritic Cell Cancer Vaccine Sales Growth

5 Americas

5.1 Americas Dendritic Cell Cancer Vaccine Sales by Country

5.1.1 Americas Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)

5.1.2 Americas Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)

5.2 Americas Dendritic Cell Cancer Vaccine Sales by Type

5.3 Americas Dendritic Cell Cancer Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dendritic Cell Cancer Vaccine Sales by Region

6.1.1 APAC Dendritic Cell Cancer Vaccine Sales by Region (2016-2021)

6.1.2 APAC Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021)

6.2 APAC Dendritic Cell Cancer Vaccine Sales by Type

6.3 APAC Dendritic Cell Cancer Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Dendritic Cell Cancer Vaccine by Country

7.1.1 Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)

7.1.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)

7.2 Europe Dendritic Cell Cancer Vaccine Sales by Type

7.3 Europe Dendritic Cell Cancer Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dendritic Cell Cancer Vaccine by Country

8.1.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type

8.3 Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Dendritic Cell Cancer Vaccine Distributors

10.3 Dendritic Cell Cancer Vaccine Customer

11 Global Dendritic Cell Cancer Vaccine Market Forecast

11.1 Global Dendritic Cell Cancer Vaccine Forecast by Region

11.1.1 Global Dendritic Cell Cancer Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Dendritic Cell Cancer Vaccine Forecast by Type

11.7 Global Dendritic Cell Cancer Vaccine Forecast by Application

12 Key Players Analysis

12.1 Medigene

12.1.1 Medigene Medigene Company Information

12.1.2 Medigene Dendritic Cell Cancer Vaccine Product Offered

12.1.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Medigene Main Business Overview

12.1.5 Medigene Latest Developments

12.2 Activarti

12.2.1 Activarti Company Information

12.2.2 Activarti Dendritic Cell Cancer Vaccine Product Offered

12.2.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Activarti Main Business Overview

12.2.5 Activarti Latest Developments

12.3 Argos Therapeutics

12.3.1 Argos Therapeutics Company Information

12.3.2 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered

12.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Argos Therapeutics Main Business Overview

12.3.5 Argos Therapeutics Latest Developments

12.4 Batavia Bioservices

12.4.1 Batavia Bioservices Company Information

12.4.2 Batavia Bioservices Dendritic Cell Cancer Vaccine Product Offered

12.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Batavia Bioservices Main Business Overview

12.4.5 Batavia Bioservices Latest Developments

12.5 Bellicum Pharmaceuticals

12.5.1 Bellicum Pharmaceuticals Company Information

12.5.2 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered

12.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Bellicum Pharmaceuticals Main Business Overview

12.5.5 Bellicum Pharmaceuticals Latest Developments

12.6 Creagene

12.6.1 Creagene Company Information

12.6.2 Creagene Dendritic Cell Cancer Vaccine Product Offered

12.6.3 Creagene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Creagene Main Business Overview

12.6.5 Creagene Latest Developments

12.7 DanDrit Biotech

12.7.1 DanDrit Biotech Company Information

12.7.2 DanDrit Biotech Dendritic Cell Cancer Vaccine Product Offered

12.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 DanDrit Biotech Main Business Overview

12.7.5 DanDrit Biotech Latest Developments

12.8 DCPrime

12.8.1 DCPrime Company Information

12.8.2 DCPrime Dendritic Cell Cancer Vaccine Product Offered

12.8.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 DCPrime Main Business Overview

12.8.5 DCPrime Latest Developments

12.9 Sanpower (Dendreon)

12.9.1 Sanpower (Dendreon) Company Information

12.9.2 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Product Offered

12.9.3 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Sanpower (Dendreon) Main Business Overview

12.9.5 Sanpower (Dendreon) Latest Developments

12.10 Elios Therapeutics

12.10.1 Elios Therapeutics Company Information

12.10.2 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered

12.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Elios Therapeutics Main Business Overview

12.10.5 Elios Therapeutics Latest Developments

12.11 Immunicum

12.11.1 Immunicum Company Information

12.11.2 Immunicum Dendritic Cell Cancer Vaccine Product Offered

12.11.3 Immunicum Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Immunicum Main Business Overview

12.11.5 Immunicum Latest Developments

12.12 Kiromic

12.12.1 Kiromic Company Information

12.12.2 Kiromic Dendritic Cell Cancer Vaccine Product Offered

12.12.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Kiromic Main Business Overview

12.12.5 Kiromic Latest Developments

12.13 Merck

12.13.1 Merck Company Information

12.13.2 Merck Dendritic Cell Cancer Vaccine Product Offered

12.13.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Merck Main Business Overview

12.13.5 Merck Latest Developments

12.14 Northwest Biotherapeutics

12.14.1 Northwest Biotherapeutics Company Information

12.14.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered

12.14.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Northwest Biotherapeutics Main Business Overview

12.14.5 Northwest Biotherapeutics Latest Developments

12.15 Glaxo Smith Kline

12.15.1 Glaxo Smith Kline Company Information

12.15.2 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product Offered

12.15.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Glaxo Smith Kline Main Business Overview

12.15.5 Glaxo Smith Kline Latest Developments

12.16 ImmunoCellular

12.16.1 ImmunoCellular Company Information

12.16.2 ImmunoCellular Dendritic Cell Cancer Vaccine Product Offered

12.16.3 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 ImmunoCellular Main Business Overview

12.16.5 ImmunoCellular Latest Developments

12.17 Tella

12.17.1 Tella Company Information

12.17.2 Tella Dendritic Cell Cancer Vaccine Product Offered

12.17.3 Tella Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Tella Main Business Overview

12.17.5 Tella Latest Developments

12.18 Vaxil Bio

12.18.1 Vaxil Bio Company Information

12.18.2 Vaxil Bio Dendritic Cell Cancer Vaccine Product Offered

12.18.3 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Vaxil Bio Main Business Overview

12.18.5 Vaxil Bio Latest Developments

12.19 Medigene

12.19.1 Medigene Company Information

12.19.2 Medigene Dendritic Cell Cancer Vaccine Product Offered

12.19.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Medigene Main Business Overview

12.19.5 Medigene Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Dendritic Cell Cancer Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of CreaVax

Table 3. Major Players of Sipuleucel-T (Provenge)

Table 4. Major Players of Others

Table 5. Global Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)

Table 6. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

Table 7. Global Dendritic Cell Cancer Vaccine Revenue by Type (2016-2021) & ($ million)

Table 8. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)

Table 9. Global Dendritic Cell Cancer Vaccine Sale Price by Type (2016-2021)

Table 10. Global Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)

Table 11. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Table 12. Global Dendritic Cell Cancer Vaccine Value by Application (2016-2021)

Table 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2016-2021)

Table 14. Global Dendritic Cell Cancer Vaccine Sale Price by Application (2016-2021)

Table 15. Global Dendritic Cell Cancer Vaccine Sales by Company (2019-2021) & (K Doses)

Table 16. Global Dendritic Cell Cancer Vaccine Sales Market Share by Company (2019-2021)

Table 17. Global Dendritic Cell Cancer Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company (2019-2021)

Table 19. Global Dendritic Cell Cancer Vaccine Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Dendritic Cell Cancer Vaccine Producing Area Distribution and Sales Area

Table 21. Players Dendritic Cell Cancer Vaccine Products Offered

Table 22. Dendritic Cell Cancer Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) (K Doses)

Table 26. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)

Table 27. Global Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)

Table 29. Americas Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)

Table 30. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)

Table 31. Americas Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)

Table 33. Americas Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)

Table 34. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

Table 35. Americas Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)

Table 36. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Table 37. APAC Dendritic Cell Cancer Vaccine Sales by Region (2016-2021) & (K Doses)

Table 38. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region (2016-2021)

Table 39. APAC Dendritic Cell Cancer Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2016-2021)

Table 41. APAC Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)

Table 42. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

Table 43. APAC Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)

Table 44. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Table 45. Europe Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)

Table 46. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)

Table 47. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)

Table 49. Europe Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)

Table 50. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

Table 51. Europe Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)

Table 52. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Country (2016-2021) & (K Doses)

Table 54. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Type (2016-2021) & (K Doses)

Table 58. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Dendritic Cell Cancer Vaccine Sales by Application (2016-2021) & (K Doses)

Table 60. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Table 61. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2021-2026) & (K Doses)

Table 62. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 63. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 64. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 65. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2021-2026) & (K Doses)

Table 66. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 67. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 68. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 69. Medigene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 70. Medigene Dendritic Cell Cancer Vaccine Product Offered

Table 71. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 72. Medigene Main Business

Table 73. Medigene Latest Developments

Table 74. Activarti Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 75. Activarti Dendritic Cell Cancer Vaccine Product Offered

Table 76. Activarti Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 77. Activarti Main Business

Table 78. Activarti Latest Developments

Table 79. Argos Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 80. Argos Therapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 81. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 82. Argos Therapeutics Main Business

Table 83. Argos Therapeutics Latest Developments

Table 84. Batavia Bioservices Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 85. Batavia Bioservices Dendritic Cell Cancer Vaccine Product Offered

Table 86. Batavia Bioservices Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 87. Batavia Bioservices Main Business

Table 88. Batavia Bioservices Latest Developments

Table 89. Bellicum Pharmaceuticals Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 90. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Offered

Table 91. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 92. Bellicum Pharmaceuticals Main Business

Table 93. Bellicum Pharmaceuticals Latest Developments

Table 94. Creagene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 95. Creagene Dendritic Cell Cancer Vaccine Product Offered

Table 96. Creagene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 97. Creagene Main Business

Table 98. Creagene Latest Developments

Table 99. DanDrit Biotech Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 100. DanDrit Biotech Dendritic Cell Cancer Vaccine Product Offered

Table 101. DanDrit Biotech Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 102. DanDrit Biotech Main Business

Table 103. DanDrit Biotech Latest Developments

Table 104. DCPrime Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 105. DCPrime Dendritic Cell Cancer Vaccine Product Offered

Table 106. DCPrime Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 107. DCPrime Main Business

Table 108. DCPrime Latest Developments

Table 109. Sanpower (Dendreon) Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 110. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Product Offered

Table 111. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 112. Sanpower (Dendreon) Main Business

Table 113. Sanpower (Dendreon) Latest Developments

Table 114. Elios Therapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 115. Elios Therapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 116. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 117. Elios Therapeutics Main Business

Table 118. Elios Therapeutics Latest Developments

Table 119. Immunicum Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 120. Immunicum Dendritic Cell Cancer Vaccine Product Offered

Table 121. Immunicum Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 122. Immunicum Main Business

Table 123. Immunicum Latest Developments

Table 124. Kiromic Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 125. Kiromic Dendritic Cell Cancer Vaccine Product Offered

Table 126. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 127. Kiromic Main Business

Table 128. Kiromic Latest Developments

Table 129. Merck Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 130. Merck Dendritic Cell Cancer Vaccine Product Offered

Table 131. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 132. Merck Main Business

Table 133. Merck Latest Developments

Table 134. Northwest Biotherapeutics Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 135. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Offered

Table 136. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 137. Northwest Biotherapeutics Main Business

Table 138. Northwest Biotherapeutics Latest Developments

Table 139. Glaxo Smith Kline Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 140. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product Offered

Table 141. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 142. Glaxo Smith Kline Main Business

Table 143. Glaxo Smith Kline Latest Developments

Table 144. ImmunoCellular Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 145. ImmunoCellular Dendritic Cell Cancer Vaccine Product Offered

Table 146. ImmunoCellular Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 147. ImmunoCellular Main Business

Table 148. ImmunoCellular Latest Developments

Table 149. Tella Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 150. Tella Dendritic Cell Cancer Vaccine Product Offered

Table 151. Tella Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 152. Tella Main Business

Table 153. Tella Latest Developments

Table 154. Vaxil Bio Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 155. Vaxil Bio Dendritic Cell Cancer Vaccine Product Offered

Table 156. Vaxil Bio Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 157. Vaxil Bio Main Business

Table 158. Vaxil Bio Latest Developments

Table 159. Medigene Basic Information, Dendritic Cell Cancer Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 160. Medigene Dendritic Cell Cancer Vaccine Product Offered

Table 161. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 162. Medigene Main Business

Table 163. Medigene Latest Developments

List of Figures

Figure 1. Picture of Dendritic Cell Cancer Vaccine

Figure 2. Dendritic Cell Cancer Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dendritic Cell Cancer Vaccine Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Dendritic Cell Cancer Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Dendritic Cell Cancer Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of CreaVax

Figure 10. Product Picture of Sipuleucel-T (Provenge)

Figure 11. Product Picture of Others

Figure 12. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020

Figure 13. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2016-2021)

Figure 14. Dendritic Cell Cancer Vaccine Consumed in Pediatrics

Figure 15. Global Dendritic Cell Cancer Vaccine Market: Pediatrics (2016-2021) & (K Doses)

Figure 16. Dendritic Cell Cancer Vaccine Consumed in Adults

Figure 17. Global Dendritic Cell Cancer Vaccine Market: Adults (2016-2021) & (K Doses)

Figure 18. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2016-2021)

Figure 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application in 2020

Figure 20. Global Dendritic Cell Cancer Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 21. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Company in 2020

Figure 22. Global Dendritic Cell Cancer Vaccine Sales Market Share by Regions (2016-2021)

Figure 23. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2020

Figure 24. Americas Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)

Figure 25. Americas Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)

Figure 26. APAC Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)

Figure 27. APAC Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)

Figure 28. Europe Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)

Figure 29. Europe Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)

Figure 30. Middle East & Africa Dendritic Cell Cancer Vaccine Sales 2016-2021 (K Doses)

Figure 31. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue 2016-2021 ($ Millions)

Figure 32. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020

Figure 33. Americas Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020

Figure 34. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020

Figure 35. Americas Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020

Figure 36. United States Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Canada Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Mexico Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. Brazil Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 40. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2020

Figure 41. APAC Dendritic Cell Cancer Vaccine Revenue Market Share by Regions in 2020

Figure 42. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020

Figure 43. APAC Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020

Figure 44. China Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Japan Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Korea Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. Southeast Asia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. India Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Australia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 50. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020

Figure 51. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020

Figure 52. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020

Figure 53. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020

Figure 54. Germany Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. France Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. UK Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Italy Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Russia Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 59. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2020

Figure 60. Middle East & Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2020

Figure 61. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020

Figure 62. Middle East & Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020

Figure 63. Egypt Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. South Africa Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Israel Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. Turkey Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. GCC Country Dendritic Cell Cancer Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

Please fill the form below, to recieve the report sample


+1